Expanding Therapeutic Choices in Atopic Dermatitis

Therapeutic options for the management of AD are rapidly growing, thanks to increasing understanding of AD pathogenesis. This educational program offers 3 CME-certified on-demand Medical Minutes highlighting recent advances in AD care.

Share

Program Content

Activities

Targeting Immunoinflammatory Pathways in AD
Targeting Immunoinflammatory Pathways in AD
Video
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2023

Expires: July 16, 2024

Slides on Pathways in AD
Expanding Therapeutic Choices in Atopic Dermatitis: Targeting Immunoinflammatory Pathways in AD
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2023

Emerging Agents in AD
Emerging Agents in AD: Current Evidence
Video
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2023

Expires: July 16, 2024

Slides on Emerging Agents in AD
Expanding Therapeutic Choices in Atopic Dermatitis: Emerging Agents in AD: Current Evidence
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2023

Personalizing Care for Patients With AD
Putting Patients First: Personalizing Care for Patients With AD
Video
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2023

Expires: July 16, 2024

Slides on Personalizing AD Care
Expanding Therapeutic Choices in Atopic Dermatitis: Putting Patients First: Personalizing Care for Patients With AD
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2023

Faculty

cover img faculity

Victoria Garcia-Albea, NP, DCNP

Director
Lahey Dermatology Nurse Practitioner Training Program
Lahey Hospital and Medical Center
Burlington, Massachusetts

cover img faculity

Benjamin Ungar, MD

Assistant Professor
Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE). 

Supporters

This activity is supported by educational grants from AbbVie Inc, Galderma, and Lilly.

AbbVie Inc.

Galderma

Lilly